Filing Details
- Accession Number:
- 0001209191-19-016328
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-05 15:18:07
- Reporting Period:
- 2019-03-01
- Accepted Time:
- 2019-03-05 15:18:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1388658 | Irhythm Technologies Inc. | IRTC | Surgical & Medical Instruments & Apparatus (3841) | 208149544 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1670676 | A David Vort | C/O Irhythm Technologies, Inc. 650 Townsend Street, Suite 500 San Francisco CA 94103 | Evp, Sales | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-03-01 | 1,838 | $97.34 | 19,839 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2019-03-04 | 5,044 | $3.65 | 24,883 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-03-04 | 5,044 | $95.89 | 19,839 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2019-03-04 | 5,044 | $0.00 | 5,044 | $3.65 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 72,960 | 2015-01-01 | 2024-02-04 | No | 4 | M | Direct |
Footnotes
- Represents shares that have been withheld by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported.
- The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2018.
- This transaction was executed in multiple trades at prices ranging from $95.01 to $96.86. The price reported above reflects the weightedaverage sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of theissuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
